Uptake, Acceptability, and Results of SARS-CoV-2 Antigen Rapid Diagnostic Testing in Community Settings in Cameroon
Authors:
- Tatiana K. DjikeussiTDTatiana K. Djikeussi
- Boris Kevin TchoungaBTBoris Kevin Tchounga
- Loic FeuzeuLFLoic Feuzeu
- Rogacien KanaRKRogacien Kana
- Boris Tchakounte YounguiBoris Tchakounte Youngui
- Shannon VianaSVShannon Viana
- Heather J. HoffmanHHHeather J. Hoffman
- Albert MamboAMAlbert Mambo
- Joseph FokamJFJoseph Fokam
- Emilienne EpéeEEEmilienne Epée
- Anne HoppeAHAnne Hoppe
Open Access
- 1 April 2025
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112 (4_Suppl) , 10-16
Abstract
: Mass gathering event restrictions were part of mitigation measures during the COVID-19 pandemic that were lifted as prevalence decreased and after vaccination rollout. We explored SARS-CoV-2 antigen rapid diagnostic test acceptability and positivity in community settings in Cameroon. In August–October 2022, community workers sensitized and referred individuals for COVID-19 testing to nearby testing points in Douala and Yaoundé. Participants consented to SARS-CoV-2 antigen rapid diagnostic testing, a survey, or both components. We describe the positivity rate, COVID-19–related history, and Likert-scale testing perceptions. Factors associated with testing acceptance were analyzed using logistic regression. Overall, 20.5% (2,449/11,945) of sensitized individuals visited testing points, and 1,864 (76.1%) were enrolled; 50.6% accepted the survey and testing (46.0% accepted survey only). Seven (0.7%) of 1,006 individuals tested positive. Most (71.8%; 1,292/1,800) considered community testing more accessible than hospital-based testing. Individuals accepting versus refusing testing differed in perceived COVID-19 risk (67%, 49%; P P P <0.001). Males (adjusted odds ratio [aOR]: 1.26 [1.04–1.53]) and those over 50 years (aOR: 1.9 [1.4–2.7]), with symptoms (aOR: 1.80 [1.30–2.50]), and at least partial vaccination (aOR: 0.76 [0.58–0.99]) were significantly associated with test acceptance. Refusal reasons included lack of perceived need for testing (33.8%) and testing discomfort (26.3%). Although community-based testing was generally perceived as important, actual testing uptake was low. In future pandemics, community testing should be optimized by addressing misinformation, offering alternative testing modalities for greater comfort, creating demand, and tailoring approaches to maximize testing uptake.Keywords
This publication has 23 references indexed in Scilit:
- SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in LuxembourgThe Lancet Regional Health - Europe, 2021
- Monitoring and evaluation of COVID-19 response in the WHO African region: challenges and lessons learnedEpidemiology and Infection, 2021
- Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample surveyThe Lancet Global Health, 2021
- The good, the bad and the ugly of lockdowns during Covid-19PLOS ONE, 2021
- The challenges of COVID-19 testing in Africa: the Ethiopian experiencePan African Medical Journal, 2021
- COVID-19 testing acceptability and uptake amongst the Rohingya and host community in Camp 21, Teknaf, BangladeshConflict and Health, 2020
- Estimate of the Basic Reproduction Number for COVID-19: A Systematic Review and Meta-analysisJournal of Preventive Medicine and Public Health, 2020
- Temporal dynamics in viral shedding and transmissibility of COVID-19Nature Medicine, 2020
- Community engagement interventions for communicable disease control in low- and lower- middle-income countries: evidence from a review of systematic reviewsInternational Journal for Equity in Health, 2020
- COVID-19 – the role of mass gatheringsTravel Medicine and Infectious Disease, 2020